Overview Dextenza in Pterygium Surgery Status: Recruiting Trial end date: 2021-07-30 Target enrollment: Participant gender: Summary DEXTENZA for the treatment of post-surgical pain and inflammation compared to standard of care topical prednisolone acetate 1% in patients who undergo pterygium surgery (excision of pterygium with conjunctival autograft) Phase: Phase 4 Details Lead Sponsor: Michelle Rhee MDCollaborator: Ocular Therapeutix, Inc.Treatments: DexamethasoneMethylprednisoloneMethylprednisolone AcetateMethylprednisolone HemisuccinatePrednisolonePrednisolone acetatePrednisolone hemisuccinatePrednisolone phosphate